The goal of this observational study is to learn about the long-term effects of aortic valve annular calcification in patients undergoing transcatheter aortic valve replacement (TAVR). The main question it aims to answer is: Does the degree of aortic valve annular calcification prior to TAVR influence long-term clinical outcomes, including major adverse cardiovascular events including all-cause mortality, over a 3-year period? Participants who have undergone TAVR as part of their regular medical care for severe aortic stenosis will have their pre-procedural imaging and clinical outcomes evaluated for a 3-year follow-up period.
Study Type
OBSERVATIONAL
Enrollment
500
Device: Edwards SAPIEN 3 valve, Medtronic Evolut valve, Boston Acurate Neo valve, or Abbott Navitor Access route: transfemorak, subclavian, transapical, transcarotid, or transcaval The use of balloon dilation will be left to the discretion of the operator.
Division of Cardiology, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea
Seoul, South Korea
RECRUITINGAll-cause mortality
Time frame: 3 years follow-up
Hospitalization for heart failure
Time frame: 3 years follow-up
Stroke
Time frame: 3 years follow-up
Myocardial infarction
Time frame: 3 years follow-up
Permanent pacemaker insertion
Time frame: 3 years follow-up
Vascular complication
Time frame: 30 days follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.